Zorana Maravic
Biographic Data
| ID | 7825955 |
|---|---|
| NAME | Zorana Maravic |
| GIVEN NAMES | Zorana |
| FAMILY NAME | Maravic |
| SIGNATURE | MARAVIC Z |
| AFFILIATIONS | European Organisation for Research and Treatment of Cancer |
| ORCID | 0000-0001-6263-0313 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment
Background: Artificial intelligence (AI) has attracted much attention because of its enormous potential in healthcare, but uptake has been slow. There are substantial barriers that challenge health technology assessment (HTA) professionals to use AI-generated evidence for decision-making from large real-world databases (e.g., based on claims data). As part of the European Commission-funded HTx H2020 (Next Generation Health Technology Assessment) …
Recommendations for patient involvement in health technology assessment in Central and Eastern European countries
Introduction: Meaningful patient involvement in health technology assessment (HTA) is essential in ensuring that the interests of the affected patient population, their families, and the general public are accurately reflected in coverage and reimbursement decisions. Central and Eastern European (CEE) countries are generally at less advanced stages of implementing HTA, which is particularly true for patient involvement activities. As part of the …
Interventions to reduce cancer screening inequities
Interventions to address cancer screening inequity currently do not adequately solve the issue, especially from the viewpoint of patients, survivors, and lay persons. Several core pathways should be focused on when designing and implementing interventions: advancing individually tailored interventions; digital tools and social media; peer-based approaches; empowerment; addressing policy and system barriers; better design of interventions; and col…
No prominent works on this page.
Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment
Background: Artificial intelligence (AI) has attracted much attention because of its enormous potential in healthcare, but uptake has been slow. There are substantial barriers that challenge health technology assessment (HTA) professionals to use AI-generated evidence for decision-making from large real-world databases (e.g., based on claims data). As part of the European Commission-funded HTx H2020 (Next Generation Health Technology Assessment) …
Recommendations for patient involvement in health technology assessment in Central and Eastern European countries
Introduction: Meaningful patient involvement in health technology assessment (HTA) is essential in ensuring that the interests of the affected patient population, their families, and the general public are accurately reflected in coverage and reimbursement decisions. Central and Eastern European (CEE) countries are generally at less advanced stages of implementing HTA, which is particularly true for patient involvement activities. As part of the …
Interventions to reduce cancer screening inequities
Interventions to address cancer screening inequity currently do not adequately solve the issue, especially from the viewpoint of patients, survivors, and lay persons. Several core pathways should be focused on when designing and implementing interventions: advancing individually tailored interventions; digital tools and social media; peer-based approaches; empowerment; addressing policy and system barriers; better design of interventions; and col…
Medicine (3 works) · Political science (3 works) · Business (2 works) · Health care (2 works) · Health Systems, Economic Evaluations, Quality of Life (2 works) · Health technology (2 works) · Public relations (2 works) · Reimbursement (2 works) · Artificial Intelligence in Healthcare and Education (1 work) · Biomedical Ethics and Regulation (1 work)